Kosuke Ichikawa Selected Research

Antineoplastic Agents (Antineoplastics)

12/2021

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kosuke Ichikawa Research Topics

Disease

13	Neoplasms (Cancer) 07/2022 - 01/2011
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2011
9	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2015
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2022 - 01/2018
2	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2021 - 01/2020
2	Pneumonia (Pneumonitis) 04/2021 - 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Diarrhea 01/2021
1	Adenocarcinoma of Lung 11/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2020
1	Brain Neoplasms (Brain Tumor) 11/2019
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Disease Progression 01/2018
1	Adenocarcinoma 01/2015
1	Lymphopenia (Lymphocytopenia) 09/2012

Drug/Important Bio-Agent (IBA)

5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2011
4	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2011
2	PlatinumIBA 09/2022 - 01/2018
2	AfatinibIBA 01/2022 - 01/2021
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 01/2018
2	LigandsIBA 01/2020 - 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2022
1	amrubicinIBA 09/2022
1	Albumin-Bound Paclitaxel FDA Link 07/2022
1	130-nm albumin-bound paclitaxelIBA 07/2022
1	AntibodiesIBA 06/2022
1	Immune Checkpoint ProteinsIBA 06/2022
1	VimentinIBA 01/2022
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2022
1	ProcalcitoninIBA 01/2022
1	Cilastatin FDA Link 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 12/2021
1	Loperamide (Imodium)FDA LinkGeneric 01/2021
1	NucleotidesIBA 11/2020
1	Ribosomal DNA (rDNA)IBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 11/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	AntigensIBA 09/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2012
1	EpitopesIBA 09/2012
1	Interleukin-23 (Interleukin 23)IBA 09/2012
1	Peptides (Polypeptides)IBA 09/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2012
1	Gefitinib (Iressa)FDA Link 01/2011

Therapy/Procedure

11	Therapeutics 09/2022 - 01/2011
6	Drug Therapy (Chemotherapy) 09/2022 - 11/2011
4	Immunotherapy 07/2015 - 11/2011
2	Radiotherapy 11/2019 - 11/2011
1	Hematopoietic Stem Cell Transplantation 04/2021
1	Drug Tapering 01/2021
1	Retreatment 01/2011